Pharmaceutical manufacturers are moving to a new way of containing the 340B drug discount program after their three-year attempt to restrict discounts to contract pharmacies apparently failed to achieve the desired results.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?